世界の豚繁殖・呼吸障害症候群ワクチン産業:成長傾向・競合分析2019-2025

【英語タイトル】Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料(QYR20FB13670)・商品コード:QYR20FB13670
・発行会社(調査会社):QYResearch
・発行日:2019年12月(※2024年版があります。お問い合わせください)
・ページ数:143
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界の豚繁殖・呼吸障害症候群ワクチン市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。豚繁殖・呼吸障害症候群ワクチンの種類別には、アクティブワクチン、不活化ワクチンに、用途別には、政府入札、市場販売に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・豚繁殖・呼吸障害症候群ワクチンの種類別市場規模:アクティブワクチン、不活化ワクチン
・豚繁殖・呼吸障害症候群ワクチンの用途別市場規模:政府入札、市場販売
・豚繁殖・呼吸障害症候群ワクチンの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:ASCENT CORPORATION、Boehringer-Ingelheim、MSD Animal Health、SPAH、Ceva、Chengdu TECH-BANK Biological Products Co,.Ltd、ringpu、QILU ANIMAL HEALTH PRODUCTS CO.,LTD、DAHUANONG、CAVAC、Komipharm、Agrovet、Bioveta、JINYU BIO-TECNOLOGY CO.,LTD、Phibro Animal Health、ANHUI TIANKANG(GROUP)SHRES O., LTD、Zoetis、WINSUN BIO、PULIKE BIOLOGICAL ENGINERING,INC.
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.Boehringer ingelheim is the company with the largest market share, about 25 percent.
In 2018, the global Swine Reproductive and Respiratory Syndrome Vaccine market size was 311.9 million US$ and is forecast to 530.9 million US in 2025, growing at a CAGR of 10.2% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Swine Reproductive and Respiratory Syndrome Vaccine.

This study researches the market size of Swine Reproductive and Respiratory Syndrome Vaccine, presents the global Swine Reproductive and Respiratory Syndrome Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Swine Reproductive and Respiratory Syndrome Vaccine in key regions like North America, Europe, China, South Korea, Japan, Southeast Asia and India, presents sales, revenue, market share, growth rate of Swine Reproductive and Respiratory Syndrome Vaccine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.

Market Segment by Product Type
Active Vaccine
Inactivated Vaccines

The segment of active vaccine holds a comparatively larger share in global market, which accounts for about 90%.

Market Segment by Application
Government Tender
Market Sales

The vaccine is fully applicated in market sales.

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Swine Reproductive and Respiratory Syndrome Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Swine Reproductive and Respiratory Syndrome Vaccine are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Type
1.3.2 Active Vaccine
1.3.3 Inactivated Vaccines
1.4 Market Segment by Application
1.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Application (2019-2025)
1.4.2 Government Tender
1.4.3 Market Sales
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size
2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2014-2025
2.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2014-2025
2.2 Swine Reproductive and Respiratory Syndrome Vaccine Growth Rate by Regions
2.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Regions 2014-2019
2.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers
3.1.1 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers 2014-2019
3.1.2 Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Swine Reproductive and Respiratory Syndrome Vaccine Price by Manufacturers
3.4 Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Swine Reproductive and Respiratory Syndrome Vaccine Market
3.6 Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Active Vaccine Sales and Revenue (2014-2019)
4.1.2 Inactivated Vaccines Sales and Revenue (2014-2019)
4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type
4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type
4.4 Swine Reproductive and Respiratory Syndrome Vaccine Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application

6 North America
6.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Company
6.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Type
6.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Application
6.4 North America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Countries
6.4.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Countries
6.4.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Company
7.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Type
7.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Application
7.4 Europe Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Countries
7.4.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Countries
7.4.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Company
8.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Type
8.3 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Application
8.4 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Countries
8.4.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Company
9.2 Central & South America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Type
9.3 Central & South America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Application
9.4 Central & South America Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Countries
9.4.1 Central & South America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Countries
9.4.2 Central & South America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Type
10.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Application
10.3 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Countries
10.3.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 ASCENT CORPORATION
11.1.1 ASCENT CORPORATION Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.1.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.1.5 ASCENT CORPORATION Recent Development
11.2 Boehringer-Ingelheim
11.2.1 Boehringer-Ingelheim Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.2.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.2.5 Boehringer-Ingelheim Recent Development
11.3 MSD Animal Health
11.3.1 MSD Animal Health Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.3.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.3.5 MSD Animal Health Recent Development
11.4 SPAH
11.4.1 SPAH Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.4.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.4.5 SPAH Recent Development
11.5 Ceva
11.5.1 Ceva Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.5.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.5.5 Ceva Recent Development
11.6 Chengdu TECH-BANK Biological Products Co,.Ltd
11.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.6.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development
11.7 ringpu
11.7.1 ringpu Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.7.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.7.5 ringpu Recent Development
11.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
11.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.8.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development
11.9 DAHUANONG
11.9.1 DAHUANONG Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.9.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.9.5 DAHUANONG Recent Development
11.10 CAVAC
11.10.1 CAVAC Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Swine Reproductive and Respiratory Syndrome Vaccine
11.10.4 Swine Reproductive and Respiratory Syndrome Vaccine Product Introduction
11.10.5 CAVAC Recent Development
11.11 Komipharm
11.12 Agrovet
11.13 Bioveta
11.14 JINYU BIO-TECNOLOGY CO.,LTD
11.15 Phibro Animal Health
11.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
11.17 Zoetis
11.18 WINSUN BIO
11.19 PULIKE BIOLOGICAL ENGINERING,INC.

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channels
12.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
12.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers

13 Market Forecast
13.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales and Revenue Forecast 2019-2025
13.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Type
13.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Application
13.4 Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Regions
13.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Regions 2019-2025
13.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer



【掲載企業】

ASCENT CORPORATION、Boehringer-Ingelheim、MSD Animal Health、SPAH、Ceva、Chengdu TECH-BANK Biological Products Co,.Ltd、ringpu、QILU ANIMAL HEALTH PRODUCTS CO.,LTD、DAHUANONG、CAVAC、Komipharm、Agrovet、Bioveta、JINYU BIO-TECNOLOGY CO.,LTD、Phibro Animal Health、ANHUI TIANKANG(GROUP)SHRES O., LTD、Zoetis、WINSUN BIO、PULIKE BIOLOGICAL ENGINERING,INC.

★調査レポート[世界の豚繁殖・呼吸障害症候群ワクチン産業:成長傾向・競合分析2019-2025] (コード:QYR20FB13670)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の豚繁殖・呼吸障害症候群ワクチン産業:成長傾向・競合分析2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆